Cook Medical said last week it promoted Umesh Patel to president of regenerative medicine and tissue-repair product developer Cook Biotech.
Patel joined Cook Biotech as an ops manager in 1995, moving to VP of development and engineering in 2000.
“I’m looking forward to leading the incredibly talented team at Cook Biotech. We will push the frontiers of advanced biomaterials and regenerative medicine in the Cook tradition of providing medical solutions for patients worldwide. It’s an exciting time to work in this field and I’m privileged to lead this part of the Cook organization,” Patel said in a prepared statement.
“Through his years with Cook, Umesh’s expertise in and passion for tissue-repair products has been instrumental in the success of Cook Biotech. These products have been sold by five of Cook Medical’s divisions as well as by seven non-Cook companies. I’m confident that with Umesh’s leadership Cook Biotech will continue to thrive in the coming years,” Cook Medical and Cook Group prez Pete Yonkman said in a press release.
Early last month, Royal Philips (NYSE:PHG) announced a number of changes to its executive roster, tapping Jeroen Tas as its chief innovation and strategy officer, Carla Kriwet as connected care & health informatics chief business leader and Ronald de Jong as global head of human resources.
Tas will replace Jean Botti, who left the company, while Kriwet will take the position left by Tas and de Jong will succeed Denise Taylor, Philips said.
“In 2016, Philips made significant progress with its strategic transformation to a focused leader in health technology and we have good momentum. Looking ahead, there is an opportunity for us to accelerate Philips’ transition to a customer-centric solutions company, and further leverage advanced informatics, artificial intelligence and the internet of things into our health propositions and our way of working. I am convinced that with the new responsibilities of Jeroen, Carla and Ronald within Philips’ executive committee, we will be able to accelerate on our journey. We are thankful for Denise’s significant contribution to shape the HR function at Philips over the last few years and we would like to wish her every success in her next endeavors. We would also like to wish Jean success for the future,” CEO Frans van Houten said in a press release.
Monarch Medical said earlier this month it tapped former Medical Technology Products CEO Linda Beneze as its new chief exec.
“After an extensive selection process, we are delighted to have Linda Beneze lead the company in an evolving and expanding market of inpatient glycemic control. Linda brings a wealth of experience in improving outcomes and enhancing patient and provider safety, alongside her unique blend of leadership experience. Linda shares our commitment to patient safety, passion for improving hospital outcomes, and excitement for our future. We look forward to strong continued growth under her leadership,” Monarch controlling firm Eigen Capital Holdings managing member Christophe Mallard said in a press release.
“I am very excited to join such an innovative and passionate company. I have seen the impact EndoTool has made on improving outcomes relative to glycemic control and I am honored to accept this opportunity to lead Monarch’s team of experts to thrive in the years to come,” Beneze said in a prepared statement.
Healthcare group Know Bio said earlier this month it launched PhotonMD and named Dr. Nicholas Medendorp Jr as its new prez & CEO.
“We started PhotonMD with one simple goal: to improve peoples’ lives using tailored photomedicine products. And to that end, we are focused on the development of medical devices that target therapeutic solutions for aesthetic applications, chronic inflammatory diseases, and other conditions susceptible to light-based healing,” Dr. Medendorp said in a prepared statement.
“Nick Medendorp brings a very diverse technology knowledge base and is highly skilled at building strong teams. Nick’s passion and tenacity are positioning PhotonMD as a dominant player in the photomedicine device market,” Know Bio chair Neal Hunter said in a press release
Biolase (NSDQ:BIOL) said earlier this month that it appointed Mark Nelson as senior VP and CFO, replacing David Dreyer who resigned on Dec. 31 last year.
Nelson previously served as CFO and COO of consumer goods start-up Beyond Meat, and CFO and treasurer of Farmer Brothers prior to that.
“Mark has exactly the right mix of broad financial expertise and general management experience that Biolase needs at this pivotal time in our continued transformation. He has been both a CFO and a COO and is highly analytical, with deep operational and manufacturing experience implementing robust business processes. He has effectively managed through turnaround and cash constrained situations. We expect his contributions across finance, operations, and corporate development to be crucial in executing our near and long term corporate objectives, and we’re happy to welcome him to the Biolase leadership team,” CEO Harold Flynn said in a prepared statement.
- Baxter GC Sharf steps down
- Atricure taps Doraiswamy as Sr VP of clinical, regulatory & scientific affairs
- Second Sight appoints Jaques as VP of R&D
- Sensile Medical forms new exec team
The post Cook Biotech taps Patel as prez | Personnel Moves – March 20, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2nM58sI
Cap comentari:
Publica un comentari a l'entrada